Apr 30, 2025, 01:00 AM by User Not Found

Bio-IT World | PacBio this week announced it is licensing advanced DNA methylation detection methods developed by Professor Dennis Lo and colleagues at The Chinese University of Hong Kong (CUHK) and Centre for Novostics to improve the methylation detection capabilities in HiFi chemistry. The licensed technology is designed to enhance PacBio HiFi sequencing with improved detection of DNA base modifications—including 5-hydroxymethylcytosine (5hmC) and hemimethylated 5-methylcytosine (5mC)—in native DNA.

Apr 29, 2025, 08:31 AM by

Apr 29, 2025, 08:31 AM by

Leader in manufacturing reagents and critical components for biomedical research partners with spatial biology solutions company to support simultaneous detection of 10+ markers in a single tissue sample using off-the-shelf antibodies and lectins

Apr 29, 2025, 01:00 AM by User Not Found

Bio-IT World | Caris will expand their platforms, MI Cancer Seek and Caris Assure; Biolinq will bring the first autonomous intradermal glucose sensor to market; and more.

Apr 28, 2025, 08:33 AM by

The release highlights the COUNTQ® Tray Inspection System, an advanced AI-enabled inspection and reconciliation system designed to revolutionize the counting and verification of vials, syringes, ampoules, and other tray-loaded parts in pharmaceutical manufacturing.

Apr 25, 2025, 08:16 AM by

Stellaromics, a pioneer in 3D spatial biology, announced its first European deployment of the Pyxa Platform through an early access partnership with Dr. Nigel Jamieson at the University of Glasgow. Dr. Jamieson’s team will use Pyxa’s 3D spatial multi-omics workflow to investigate tumor architecture and the surrounding microenvironment, work that could inform new biomarker discoveries and advance future cancer diagnostics and therapies.

Apr 25, 2025, 08:16 AM by

EpiCypher® has announced the launch of CUTANA® meCUT&RUN and Multiomic CUT&RUN, two novel DNA methylation sequencing technologies advancing the frontiers of genomic research and drug discovery.

Apr 25, 2025, 01:00 AM by User Not Found

Bio-IT World | The integration of artificial intelligence (AI) into precision medicine is transforming healthcare by enabling more personalized treatment strategies. However, along with these advancements come significant ethical considerations. AI must be implemented such that it enhances, rather than replaces, the physician-patient relationship while maintaining patient autonomy, transparency, and explainability in clinical decision-making.

Apr 24, 2025, 08:29 AM by

The press release highlights key advantages of the Green DNA/RNA Dry Transport System: it eliminates the need for cold chain logistics (such as dry ice and Styrofoam), drastically reducing environmental impact and shipping costs, while maintaining the integrity of DNA and RNA samples at room temperature. This innovation is ideal for transporting sequencing-ready libraries for any commercial platform, making it especially valuable for researchers and professionals needing fast, reliable, and sustainable sample transport solutions.

Apr 24, 2025, 08:29 AM by

Apr 24, 2025, 08:29 AM by

Apr 24, 2025, 08:29 AM by

Biodesix, Inc (Nasdaq: BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and diagnostics products, contributed to new research findings from Friends of Cancer Research’s (Friends’) ctMoniTR Project, recently published in Clinical Cancer Research (CCR).

Apr 24, 2025, 08:29 AM by

BioSkryb Genomics and Ultima Genomics have launched a joint grant program to accelerate oncology research by providing scientists with access to cutting-edge multi-omic and sequencing technologies. The collaboration pairs BioSkryb’s ultra–low-input single-cell and multi-omic platforms with Ultima’s scalable, cost-efficient sequencing, enabling researchers to explore complex cancer biology with high resolution and reduced cost barriers. The grant will award selected projects with comprehensive studies covering up to 2,000 single-cell genomes at no charge, prioritizing innovative work in somatic mosaicism, clonal heterogeneity, residual disease, and ultra–low-input samples. Applications are due June 20, 2025.

Apr 24, 2025, 08:29 AM by

Real-world evidence supports Viz ICH Plus for reliable volume and midline shift estimation.

Apr 23, 2025, 01:00 AM by User Not Found

Bio-IT World | After years of contributing to the Bio-IT World community as a speaker, awards program judge, and leading consultant, technology expert Chris Dwan took the plenary stage at the 2025 Bio-IT World Conference & Expo, sharing wisdom gleaned from over two decades of building computing infrastructures for the New York Genome Center, Broad Institute, and Sema4 and others.

Apr 22, 2025, 08:15 AM by

New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows

Apr 22, 2025, 08:15 AM by

Symbiosis Pharmaceutical Services, a specialist sterile manufacturing CMO, who has been formally recognised by EcoVadis for its continued commitment to sustainability.

Apr 22, 2025, 01:00 AM by User Not Found

Bio-IT World | An expert panel of technology and pharmaceutical executives convened at this month's Bio-IT World Venture, Innovation, and Partnering event to discuss the transformative potential of artificial intelligence in drug development—and the significant challenges that still lie ahead. Participants included Rory Kelleher of NVIDIA, Bill Fitzgerald from Google Cloud, Bill Mayo of Bristol-Myers Squibb, Anthony Philippakis of GV (formerly Google Ventures), and Becky Stevenson of HSBC, moderated by Jeremy Goldberg of Arsenal Capital Partners.

Apr 17, 2025, 01:00 AM by User Not Found

Bio-IT World | At the Bio-IT World Conference & Expo earlier this month, Alex Zhavoronkov, CEO and founder of Insilico Medicine, shared the company's progress in leveraging generative AI to accelerate drug discovery, particularly focusing on aging research. Celebrating the company's 11th year, Zhavoronkov emphasized his singular mission: helping people live longer, healthier lives.

Apr 16, 2025, 06:40 AM by

CluePoints, provider of leading statistical and AI-driven software solutions, has been named as a finalist in the ‘Innovative Clinical Trial Solutions’ category at the 2025 Citeline Awards.